Works matching IS 0008543X AND DT 2014 AND VI 120 AND IP 7

Results: 26
    1
    2
    3
    4
    5

    Racial variation in the quality of surgical care for bladder cancer.

    Published in:
    Cancer (0008543X), 2014, v. 120, n. 7, p. 1018, doi. 10.1002/cncr.28520
    By:
    • Barocas, Daniel A.;
    • Alvarez, JoAnn;
    • Koyama, Tatsuki;
    • Anderson, Christopher B.;
    • Gray, Darryl T.;
    • Fowke, Jay H.;
    • You, Chaochen;
    • Chang, Sam S.;
    • Cookson, Michael S.;
    • Smith, Joseph A.;
    • Penson, David F.
    Publication type:
    Article
    6
    7
    8
    9

    Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: Results from Cancer and Leukemia Group B 19808.

    Published in:
    Cancer (0008543X), 2014, v. 120, n. 7, p. 1010, doi. 10.1002/cncr.28516
    By:
    • Kolitz, Jonathan E.;
    • George, Stephen L.;
    • Benson, Don M.;
    • Maharry, Kati;
    • Marcucci, Guido;
    • Vij, Ravi;
    • Powell, Bayard L.;
    • Allen, Steven L.;
    • DeAngelo, Daniel J.;
    • Shea, Thomas C.;
    • Stock, Wendy;
    • Bakan, Courtney E.;
    • Hars, Vera;
    • Hoke, Eva;
    • Bloomfield, Clara D.;
    • Caligiuri, Michael A.;
    • Larson, Richard A.
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17

    Drug resistance and BCR-ABL kinase domain mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia from the imatinib to the second-generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the frequency of mutation involvement

    Published in:
    Cancer (0008543X), 2014, v. 120, n. 7, p. 1002, doi. 10.1002/cncr.28522
    By:
    • Soverini, Simona;
    • De Benedittis, Caterina;
    • Papayannidis, Cristina;
    • Paolini, Stefania;
    • Venturi, Claudia;
    • Iacobucci, Ilaria;
    • Luppi, Mario;
    • Bresciani, Paola;
    • Salvucci, Marzia;
    • Russo, Domenico;
    • Sica, Simona;
    • Orlandi, Ester;
    • Intermesoli, Tamara;
    • Gozzini, Antonella;
    • Bonifacio, Massimiliano;
    • Rigolin, Gian Matteo;
    • Pane, Fabrizio;
    • Baccarani, Michele;
    • Cavo, Michele;
    • Martinelli, Giovanni
    Publication type:
    Article
    18
    19
    20
    21

    An open-label, single-arm, phase 2 trial of the polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer.

    Published in:
    Cancer (0008543X), 2014, v. 120, n. 7, p. 976, doi. 10.1002/cncr.28519
    By:
    • Stadler, Walter M.;
    • Vaughn, David J.;
    • Sonpavde, Guru;
    • Vogelzang, Nicholas J.;
    • Tagawa, Scott T.;
    • Petrylak, Daniel P.;
    • Rosen, Peter;
    • Lin, Chia‐Chi;
    • Mahoney, John;
    • Modi, Sanjiv;
    • Lee, Peter;
    • Ernstoff, Marc S.;
    • Su, Wu‐Chou;
    • Spira, Alexander;
    • Pilz, Korinna;
    • Vinisko, Richard;
    • Schloss, Charles;
    • Fritsch, Holger;
    • Zhao, Charles;
    • Carducci, Michael A.
    Publication type:
    Article
    22
    23

    Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer.

    Published in:
    Cancer (0008543X), 2014, v. 120, n. 7, p. 1076, doi. 10.1002/cncr.28536
    By:
    • Hoppe, Bradford S.;
    • Michalski, Jeff M.;
    • Mendenhall, Nancy P.;
    • Morris, Christopher G.;
    • Henderson, Randal H.;
    • Nichols, Romaine C.;
    • Mendenhall, William M.;
    • Williams, Christopher R.;
    • Regan, Meredith M.;
    • Chipman, Jonathan J.;
    • Crociani, Catrina M.;
    • Sandler, Howard M.;
    • Sanda, Martin G.;
    • Hamstra, Daniel A.
    Publication type:
    Article
    24

    Anaplastic rhabdomyosarcoma in TP53 germline mutation carriers.

    Published in:
    Cancer (0008543X), 2014, v. 120, n. 7, p. 1068, doi. 10.1002/cncr.28507
    By:
    • Hettmer, Simone;
    • Archer, Natasha M.;
    • Somers, Gino R.;
    • Novokmet, Ana;
    • Wagers, Amy J.;
    • Diller, Lisa;
    • Rodriguez‐Galindo, Carlos;
    • Teot, Lisa A.;
    • Malkin, David
    Publication type:
    Article
    25

    Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration-resistant prostate cancer who progress after docetaxel and abiraterone treatment.

    Published in:
    Cancer (0008543X), 2014, v. 120, n. 7, p. 968, doi. 10.1002/cncr.28518
    By:
    • Badrising, Sushil;
    • van der Noort, Vincent;
    • van Oort, Inge M.;
    • van den Berg, H. Pieter;
    • Los, Maartje;
    • Hamberg, Paul;
    • Coenen, Jules L.;
    • van den Eertwegh, Alfons J. M.;
    • de Jong, Igle J.;
    • Kerver, Emile D.;
    • van Tinteren, Harm;
    • Bergman, Andries M.
    Publication type:
    Article
    26